Genetix Raises $35 million
Genetix Pharmaceuticals, a gene therapy company developing treatments for severe genetic disorders, completed a $35 million Series B financing with new investors Third Rock Ventures and Genzyme Ventures joining TVM Capital, Forbion and Easton Capital.
12 March 2010•4 mins read
